This Kalorama Information report, IVD Procedure Volumes and Pricing Analysis, takes an informative look at worldwide procedure volumes for IVD tests. The report provides global 2014 sales of equipment, reagents and other products related to in vitro diagnostic tests.
Market estimates for each major market segment represent global revenues and are expressed in current dollars. Segments covered include:
Point-of-Care (OTC Total, Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose, Infectious Disease, Critical Care, Other)
Molecular (Infectious Disease [inc. molecular tests for HIV, Hepatitis, STDs, HAI, Respiratory, Other], Oncology, Inherited Disease, Other)
Coagulation (PT, PTT)
Microbiology (Automated Panels, Manual Panels, Blood Culture, Chromogenic Media)
Core lab (General Chemistries, Blood Gas Analyzers, Urinalysis, Immunoassays Infectious Disease, Cardiac Markers, Diabetes/HbA1c, Autoimmune)
Histology/Cytology (Pap, Non-Pap, Image Cytometry, Flow Cytometry, ISH, IHC, CTCs)
There are several approaches to examining a market, the most prominent being sales analysis and procedure analysis (how many procedures performed). Both are useful for business planners to construct models and size up opportunties in their field. Pricing trend analysis is provided for each category. For each test type, estimates are provided for the historic 2014 period and forecasts are provided through 2019. Price estimates are offered for leading products, systems and equipment; these represent average list prices
Diagnostic equipment has transformed in the past few years, due to the publication of the human genome project and advances in functional genomics, bioinformatics, automation, miniaturization and microelectronics as well as rapid development and proliferation of novel telecommunications technologies.
This report, IVD Procedure Volumes and Pricing Analysis is a one of a kind reprot that demonstrates to readers which companies are performing what share of IVD procedures in the market. The following IVD leaders are profiled and their procedure volumes are analyzed in this report:
Thermo Fisher Scientific
Beckman Coulter, Inc./Danaher
Becton, Dickinson & Co.
Bio-RAD Laboratories, Inc.
Laboratory Corporation of America
Ortho Clinical Diagnostics
Clarient, Inc./GE Healthcare